Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences Statistics

Total Valuation

NERV has a market cap or net worth of $32.87 million. The enterprise value is $77.62 million.

Market Cap	32.87M
Enterprise Value	77.62M

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

NERV has 6.99 million shares outstanding. The number of shares has decreased by -0.05% in one year.

Current Share Class	6.99M
Shares Outstanding	6.99M
Shares Change (YoY)	-0.05%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.02%
Owned by Institutions (%)	28.08%
Float	5.44M

Valuation Ratios

The trailing PE ratio is 3.17.

PE Ratio	3.17
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	6.91
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.15

Current Ratio	6.15
Quick Ratio	6.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-26.34%
Return on Invested Capital (ROIC)	-28.88%
Return on Capital Employed (ROCE)	-57.96%
Revenue Per Employee	n/a
Profits Per Employee	$1.40M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +91.84% in the last 52 weeks. The beta is -0.32, so NERV's price volatility has been lower than the market average.

Beta (5Y)	-0.32
52-Week Price Change	+91.84%
50-Day Moving Average	2.53
200-Day Moving Average	1.98
Relative Strength Index (RSI)	65.62
Average Volume (20 Days)	9,258,579

Short Selling Information

The latest short interest is 58,678, so 0.84% of the outstanding shares have been sold short.

Short Interest	58,678
Short Previous Month	38,956
Short % of Shares Out	0.84%
Short % of Float	1.08%
Short Ratio (days to cover)	0.10

Income Statement

Revenue	n/a
Gross Profit	-6.53M
Operating Income	-16.17M
Pretax Income	11.23M
Net Income	11.23M
EBITDA	-16.16M
EBIT	-16.17M
Earnings Per Share (EPS)	$1.48

Balance Sheet

The company has $15.25 million in cash and $60.00 million in debt, giving a net cash position of -$44.75 million or -$6.40 per share.

Cash & Cash Equivalents	15.25M
Total Debt	60.00M
Net Cash	-44.75M
Net Cash Per Share	-$6.40
Equity (Book Value)	-32.11M
Book Value Per Share	-4.59
Working Capital	13.02M

Cash Flow

Operating Cash Flow	-15.63M
Capital Expenditures	n/a
Free Cash Flow	-15.63M
FCF Per Share	-$2.24

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NERV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.05%
Shareholder Yield	0.05%
Earnings Yield	34.16%
FCF Yield	-47.56%

Analyst Forecast

The average price target for NERV is $5.00, which is 6.38% higher than the current price. The consensus rating is "Hold".

Price Target	$5.00
Price Target Difference	6.38%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 21, 2022. It was a reverse split with a ratio of 1:8.

Last Split Date	Jun 21, 2022
Split Type	Reverse
Split Ratio	1:8

Scores

Altman Z-Score	n/a
Piotroski F-Score	2